Advisory Research’s ICU Medical ICUI Stock Holding History

Advisory Research’s Portfolio ICUI Stock Details ICUI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-16,300	Closed	-$1.84M	–	270
2015 Q4	$1.84M	Buy	16,300 +1,900	+13%	+$210K	0.03%	159
2015 Q3	$1.58M	Buy	+14,400	New	+$1.54M	0.02%	178

Other funds holding ICUI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Advisory Research's ICUI Position: Q1 2016 in Review

Advisory Research sold out of ICU Medical (ICUI) in Q1 2016, closing a stake of 16,300 shares — an estimated $1.84M sold.

Advisory Research first reported a position in ICUI in Q3 2015 and held it in 2 quarters. The position peaked at $1.84M in Q4 2015. 216 funds tracked by Wall St. Rank hold ICUI as of Q1 2016.

Advisory Research reported no remaining ICU Medical position as of Q1 2016 after selling out during the quarter.
Advisory Research sold 16,300 ICU Medical shares in Q1 2016, an estimated $1.84M.
Advisory Research first reported a position in ICU Medical in Q3 2015 and held it in 2 quarters.
Advisory Research's ICU Medical position peaked at $1.84M in Q4 2015.
216 funds tracked by Wall St. Rank held ICU Medical as of Q1 2016.

Based on Advisory Research's 13F filing for Q1 2016, filed 16 May 2016.